The use of 10-23 DNAzyme to selectively destroy the allele of mRNA with a unique purine-pyrimidine dinucleotide

Oligonucleotides

Volumn 18, Issue 3, 2008, Pages 295-299

  Wang, Tong Hong ^a,b   Li, Wan Ting ^b   Yu, Szu Hsien ^a   Au, Lo Chun ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DINUCLEOTIDE; DNA; MESSENGER RNA; MUTANT PROTEIN; PROTEIN P53; PURINE; PYRIMIDINE;

ALLELE; ARTICLE; CODON; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA DEGRADATION; WILD TYPE;

ALLELES; CELL LINE, TUMOR; DNA, CATALYTIC; DNA, SINGLE-STRANDED; GENES, P53; HUMANS; OLIGONUCLEOTIDES; PURINES; PYRIMIDINES; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 51849115599     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2008.0138     Document Type: Article

References (18)

1. BEEN, M.D. (2006). Molecular biology. Versatility of self-cleaving ribozymes. Science 313, 1745-1747.
2. CADWELL, C., and ZAMBETTI, G.P. (2001). The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 277, 15-30.
3. CAIRNS, M.J., KING, A., and SUN, L.Q. (2000). Nucleic acid mutation analysis using catalytic DNA. Nucleic Acids Res. 28, E9.
4. CIESLAK, M., SZYMANSKI, J., ADAMIAK, R.W., and CIERNIEWSKI, C.S. (2003). Structural rearrangements of the 10-23 DNAzyme to beta 3 integrin subunit mRNA induced by cations and their relations to the catalytic activity. J. Biol. Chem. 278, 47987-47996.
5. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
6. FAHMY, R.G., WALDMAN, A., ZHANG, G., MITCHELL, A., TEDLA, N., CAI, H., GECZY, C.R., CHESTERMAN, C.N., PERRY, M., and KHACHIGIAN, L.M. (2006). Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun. Nat. Biotechnol. 24, 856-863.
7. FAULHAMMER, D., and FAMULOK, M. (1997). Characterization and divalent metal-ion dependence of in vitro selected deoxyribozymes which cleave DNA/RNA chimeric oligonucleotides. J. Mol. Biol. 269, 188-202.
8. GRIMM, D., and KAY, M.A. (2007). Therapeutic application of RNAi: is mRNA targeting 2 nally ready for prime time? J. Clin. Invest. 117, 3633-3641.
9. ROMANI, A., and SCARPA, A. (1992). Regulation of cell magnesium. Arch. Biochem. Biophys. 298, 1-12.
10. SANTORO, S.W., and JOYCE, G.F. (1997). A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. USA 94, 4262-4266.
11. SCHUBERT, S., FURSTE, J.P., WERK, D., GRUNERT, H.P., ZEICHHARDT, H., ERDMANN, V.A., and KURRECK, J. (2004). Gaining target access for deoxyribozymes. J. Mol. Biol. 339, 355-363.
12. SHIEH, S.Y., IKEDA, M., TAYA, Y., and PRIVES, C. (1997). DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334.
13. TAKAMORI, K., KUBO, T., ZHELEV, Z., RUMIANA, B., OHBA, H., DOI, K., and FUJII, M. (2005). Suppression of bcr/abl chimeric gene by conjugate DNA enzymes in human cells. Nucleic Acids Symp. Ser. (Oxf.) 49, 333-334.
14. WANG, D.Y., LAI, B.H., FELDMAN, A.R., and SEN, D. (2002). A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes. Nucleic Acids Res. 30, 1735-1742.
15. WANG, T.H., YU, S.H., and AU, L.C. (2008). Facilitated in vivo synthesis of ribonucleic acid and protein via T7 RNA polymerase. Anal. Biochem. 375, 97-104.
16. YEN, L., SVENDSEN, J., LEE, J.S., GRAY, J.T., MAGNIER, M., BABA, T., D'AMATO, R.J., and MULLIGAN, R.C. (2004). Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. Nature 431, 471-476.
17. 2+ concentration for maximal catalytic activity. Int. J. Biochem. Cell. Biol. 39, 1119-1129.
18. ZHANG, G., LUO, X., SUMITHRAN, E., PUA, V.S., BARNETSON, R.S., HALLIDAY, G.M., and KHACHIGIAN, L.M. (2006). Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression. Oncogene 25, 7260-7266.